Cytodyn Inc (CYDY)

[SmileyRiley_595]

I haven’t voted my proxy yet and not defending executive compensation by any means... if I had to vote today, my answer would likely be no for the 25 million shares...

But, I’ve been doing some research to put things into perspective... The CEO at IMMU, Michael Pehl made $3,583,403 in total compensation IN 2018. Salary= 364,182, Bonus = $216,723, Stock Options = 3,002,498, $0 was awarded as stock or other types of compensation. This information is from proxy statements filed for 2018 fiscal year.

His compensation was without an approved drug and multiple RTF’s under his belt....

Comparing the timeline... IMMU was ~2 years away from an approval... CytoDyn is 6-12 months (maybe sooner).


I think we all had the same reaction when we saw the share request in the 14A... With that said, the intent of this post is to illustrate my effort to take the emotions out of my decision and to have a balanced view on the board recommendation... I will likely still vote no for the request but I didn’t want to simply react out of frustration before I made a final decision. GLTA!!!